In late October 2020, three more reimbursable health apps were introduced on the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM). These applications can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers.
Now besides Kalmeda, Velibra, Somnio, Vivira, and Zanadio, introduced in October 2020, one more health app is are available at the DiGA Directory.
The Invirto – The therapy against fear (Sympatient GmbH, Germany) is a digital application for the home treatment of agoraphobia, social phobias, and panic disorder. The app is accompanied by virtual reality glasses, provided both for the patients and doctors. Invirto is based on cognitive behavioral therapy with exposure training. The app is available only in German.
The statutory health insurance will fully cover the price of the app, which amounts to €428.40.
The full details in German can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.